Literature DB >> 32487658

Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.

Hiroe Tada1, Hideyuki Takahashi1, Shota Ida1, Yurino Nagata1, Kazuaki Chikamatsu2.   

Abstract

BACKGROUND/AIM: We aimed to elucidate the clinical implication of the epithelial-mesenchymal plasticity of circulating tumor cells (CTCs) in patients with head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS: CTCs isolated from 44 patients with non-recurrent/metastatic HNSCC and 42 with recurrent/metastatic (R/M) HNSCC were classified into four epithelial-mesenchymal transition (EMT) statuses based on the expression of epithelial (keratin 19) and mesenchymal (vimentin) markers and the relationships between EMT status in CTCs and clinical factors were investigated.
RESULTS: E+M- CTC phenotype was more frequent in patients without recurrence/metastasis (p=0.0468) and was also more frequent in those with a complete response (p=0.0346). The E+M+ phenotype constituted the major proportion of the CTCs detected in patients with R/M HNSCC (p=0.0374).
CONCLUSION: CTCs may play unique roles at various stages of metastasis through transitioning from epithelial to mesenchymal phenotypes. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Epithelial–mesenchymal transition; circulating tumor cell; head and neck squamous cell carcinoma; metastasis; recurrence

Year:  2020        PMID: 32487658     DOI: 10.21873/anticanres.14345

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Application of circulating tumour cells to predict response to treatment in head and neck cancer.

Authors:  Xi Zhang; Chameera Ekanayake Weeramange; Brett G M Hughes; Sarju Vasani; Zhen Yu Liu; Majid Ebrahimi Warkiani; Gunter Hartel; Rahul Ladwa; Jean Paul Thiery; Liz Kenny; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2022-06-23       Impact factor: 7.051

2.  Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients.

Authors:  Spyridoula D Katsarou; Ippokratis Messaritakis; Anastasia Voumvouraki; Stavros Kakavogiannis; Athanasios Κotsakis; Saad Alkahtani; Christos Stournaras; Stuart S Martin; Vassilis Georgoulias; Galatea Kallergi
Journal:  J Pers Med       Date:  2022-01-25

Review 3.  A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Authors:  Benjamin Genenger; Jay R Perry; Bruce Ashford; Marie Ranson
Journal:  Discov Oncol       Date:  2022-06-06

Review 4.  Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.

Authors:  Vasudha Mishra; Alka Singh; Xiangying Chen; Ari J Rosenberg; Alexander T Pearson; Alex Zhavoronkov; Peter A Savage; Mark W Lingen; Nishant Agrawal; Evgeny Izumchenko
Journal:  Br J Cancer       Date:  2021-12-07       Impact factor: 7.640

Review 5.  Partial EMT in head and neck cancer biology: a spectrum instead of a switch.

Authors:  Ananya Pal; Thomas F Barrett; Rachel Paolini; Anuraag Parikh; Sidharth V Puram
Journal:  Oncogene       Date:  2021-07-08       Impact factor: 8.756

6.  Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.

Authors:  Hiroe Tada; Hideyuki Takahashi; Reika Kawabata-Iwakawa; Yurino Nagata; Miho Uchida; Masato Shino; Shota Ida; Ikko Mito; Toshiyuki Matsuyama; Kazuaki Chikamatsu
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

7.  Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer.

Authors:  Kuan-Chou Lin; Lai-Lei Ting; Chia-Lun Chang; Long-Sheng Lu; Hsin-Lun Lee; Fang-Chi Hsu; Jeng-Fong Chiou; Peng-Yuan Wang; Thierry Burnouf; Dennis Chun-Yu Ho; Kai-Chiang Yang; Chang-Yu Chen; Chu-Huang Chen; Ching-Zong Wu; Yin-Ju Chen
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

8.  A preliminary study on the association between epithelial-mesenchymal transition and circulating tumor cells in renal cell carcinoma.

Authors:  Huansheng Wang; Hao Li; Yinping Yuan; Ting Hao; Benkui Zou; Bing Yu; Sheng Li; Jianbo Zhang
Journal:  Transl Androl Urol       Date:  2022-04

9.  Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.

Authors:  Xiao-Xiang Jie; Meng Zhang; Ming Du; Qing-Qing Cai; Qing Cong; Cong-Jian Xu; Xiao-Yan Zhang
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 10.  Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma.

Authors:  Glenn Geidel; Isabel Heidrich; Julian Kött; Stefan W Schneider; Klaus Pantel; Christoffer Gebhardt
Journal:  NPJ Precis Oncol       Date:  2022-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.